{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:43:35Z","timestamp":1793400215774,"version":"4.5.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00119","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T04:25:23Z","timestamp":1548995123000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":569,"title":["The Immunology of Macrophage Activation Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Courtney B.","family":"Crayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrin","family":"Albeituni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy Q.","family":"Cron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"Stephan","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"B3","first-page":"121","article-title":"Is macrophage activation syndrome a new entity?","volume":"20","author":"Athreya","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases","volume":"129","author":"Mouy","year":"1996","journal-title":"J Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J Rheumatol."},{"key":"B8","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MPH.0000000000000872","article-title":"Kawasaki disease complicated with macrophage activation syndrome: a systematic review","volume":"39","author":"Garcia-Pavon","year":"2017","journal-title":"J Pediatr Hematol Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.40417","article-title":"Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus","volume":"70","author":"Borgia","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","article-title":"Macrophage activation syndrome in the course of monogenic autoinflammatory disorders","volume":"34","author":"Rigante","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2017.08.004","article-title":"Hemophagocytic syndrome: primary forms and predisposing conditions","volume":"49","author":"Sepulveda","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-018-4114-1","article-title":"Are the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?","volume":"39","author":"Tada","year":"2019","journal-title":"Rheumatol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","article-title":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine","volume":"128","author":"Ravelli","year":"1996","journal-title":"J Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5304180","DOI":"10.1155\/2017\/5304180","article-title":"Macrophage activation syndrome: a report of two cases and a literature review","volume":"2017","author":"Alkoht","year":"2017","journal-title":"Case Rep Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B19","first-page":"21","article-title":"Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis","volume":"42","author":"Goel","year":"2012","journal-title":"Ann Clin Lab Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.hoc.2015.06.007","article-title":"Pathogenesis of hemophagocytic lymphohistiocytosis","volume":"29","author":"Filipovich","year":"2015","journal-title":"Hematol Oncol Clin North Am."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.4049\/jimmunol.1500774","article-title":"Kill or be killed","volume":"194","author":"Behrens","year":"2015","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-0-387-72005-0_23","article-title":"The lytic NK cell immunological synapse and sequential steps in its formation","volume":"601","author":"Orange","year":"2007","journal-title":"Adv Exp Med Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur","year":"2005","journal-title":"Hum Mol Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-0142(19850801)56:3<524::AID-CNCR2820560320>3.0.CO;2-Z","article-title":"The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?","volume":"56","author":"Rubin","year":"1985","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1182\/blood-2005-11-4413","article-title":"Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II","volume":"108","author":"Enders","year":"2006","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J Exp Med."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.187.11.1903","article-title":"Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus","volume":"187","author":"Binder","year":"1998","journal-title":"J Exp Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/art.37958","article-title":"Interferon-\u03b3 mediates anemia but is dispensable for Fulminant Toll-Like receptor 9-induced macrophage activation syndrome and hemophagocytosis","volume":"65","author":"Canna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De","year":"2012","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3899\/jrheum.100726","article-title":"Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series","volume":"38","author":"Record","year":"2011","journal-title":"J Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2015-07-659813","article-title":"ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice","volume":"127","author":"Rood","year":"2016","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","article-title":"Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome","volume":"141","author":"Prencipe","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3899\/jrheum.170370","article-title":"Weathering a macrophage storm","volume":"44","author":"Crayne","year":"2017","journal-title":"J Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","article-title":"Genetic defects in cytolysis in macrophage activation syndrome","volume":"16","author":"Zhang","year":"2014","journal-title":"Curr Rheumatol Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1084\/jem.20131131","article-title":"Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency","volume":"211","author":"Cichocki","year":"2014","journal-title":"J Exp Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/art.40438","article-title":"Brief report: novel UNC13D intronic variant disrupting an NF-kappaB enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1182\/blood-2014-11-610816","article-title":"Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion","volume":"125","author":"Spessott","year":"2015","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","article-title":"A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis","volume":"196","author":"Zhang","year":"2016","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","article-title":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza","volume":"213","author":"Schulert","year":"2016","journal-title":"J Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3899\/jrheum.121233","article-title":"Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome","volume":"40","author":"Strippoli","year":"2013","journal-title":"J Rheumatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/intimm\/dxy012","article-title":"Convergent pathways of the hyperferritinemic syndromes","volume":"30","author":"Schulert","year":"2018","journal-title":"Int Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2007.11.025","article-title":"Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?","volume":"7","author":"Behrens","year":"2008","journal-title":"Autoimmun Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood-2001-11-0061","article-title":"Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model","volume":"101","author":"Jordan","year":"2003","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jaci.2014.11.030","article-title":"Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-gamma receptor deficiency","volume":"135","author":"Tesi","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1309\/QHD6YFN81KQXUUH6","article-title":"CD163: a specific marker of macrophages in paraffin-embedded tissue samples","volume":"122","author":"Lau","year":"2004","journal-title":"Am J Clin Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the haemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","article-title":"Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood","volume":"148","author":"Avcin","year":"2006","journal-title":"J Pediatr."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/rheumatology\/keh710","article-title":"Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?","volume":"44","author":"Ramanan","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"Moller","year":"2002","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1006\/bbrc.1999.0294","article-title":"Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family","volume":"256","author":"Droste","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","article-title":"Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome","volume":"74","author":"Schaer","year":"2005","journal-title":"Eur J Haematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cyto.2018.05.017","article-title":"Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis","volume":"110","author":"Sakumura","year":"2018","journal-title":"Cytokine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2009-11-255174","article-title":"Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation","volume":"116","author":"Milner","year":"2010","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/JLB.2A0317-107R","article-title":"MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms","volume":"103","author":"Do","year":"2018","journal-title":"J Leuk Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.RES.0000247067.34173.1b","article-title":"Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin","volume":"99","author":"Schaer","year":"2006","journal-title":"Circ Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","article-title":"Heme oxygenase-1: unleashing the protective properties of heme","volume":"24","author":"Otterbein","year":"2003","journal-title":"Trends Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"8798","DOI":"10.1073\/pnas.161272598","article-title":"Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia","volume":"98","author":"Minamino","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fphar.2014.00079","article-title":"H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice","volume":"5","author":"Vercellotti","year":"2014","journal-title":"Front Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1189\/jlb.0504272","article-title":"Functional plasticity of macrophages: reversible adaptation to changing microenvironments","volume":"76","author":"Stout","year":"2004","journal-title":"J Leuk Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","article-title":"Making Sense of the cytokine storm: a conceptual framework for understanding, diagnosing and treating hemophagocytic syndromes","volume":"59","author":"Canna","year":"2012","journal-title":"Pediatr Clin North Am."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.celrep.2015.08.033","article-title":"TNF Counterbalances the emergence of M2 tumor macrophages","volume":"12","author":"Kratochvill","year":"2015","journal-title":"Cell Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11882-013-0351-2","article-title":"Update on the treatment of juvenile idiopathic arthritis","volume":"13","author":"Harris","year":"2013","journal-title":"Curr Allergy Asthma Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","article-title":"Treatment of juvenile idiopathic arthritis: a revolution in care","volume":"12","author":"Stoll","year":"2014","journal-title":"Pediatr Rheumatol Online J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000338179","article-title":"Critical imbalance of TNF-alpha and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment","volume":"128","author":"Flammiger","year":"2012","journal-title":"Acta Haematol."},{"key":"B86","first-page":"443","article-title":"Macrophage activation syndrome induced by etanercept in a patient with systemic sclerosis","volume":"12","author":"Sterba","year":"2010","journal-title":"Israel Med Assoc J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00296-011-2319-7","article-title":"Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome","volume":"33","author":"Buonuomo","year":"2013","journal-title":"Rheumatol Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"de","year":"1991","journal-title":"Arthritis Rheum."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e20014","DOI":"10.1371\/journal.pone.0020014","article-title":"Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients","volume":"6","author":"Lasiglie","year":"2011","journal-title":"PLoS ONE"},{"key":"B90","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"B93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11926-016-0593-9","article-title":"Biologics in pediatric rheumatology: Quo Vadis?","volume":"18","author":"Sterba","year":"2016","journal-title":"Curr Rheumatol Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3899\/jrheum.140288","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab","volume":"42","author":"Yokota","year":"2015","journal-title":"J Rheumatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B97","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood.V76.12.2466.2466","article-title":"Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes","volume":"76","author":"Musso","year":"1990","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/1521-4141(200010)30:10<3057::AID-IMMU3057>3.0.CO;2-P","article-title":"Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta","volume":"30","author":"Netea","year":"2000","journal-title":"Eur J Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1002\/pmic.201000298","article-title":"Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications","volume":"10","author":"Ling","year":"2010","journal-title":"Proteomics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: Biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/cei.13026","article-title":"Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis","volume":"191","author":"Shimizu","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","article-title":"Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature","volume":"37","author":"Sonmez","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc'h","year":"2018","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/imr.12607","article-title":"The NLRC4 inflammasome","volume":"281","author":"Duncan","year":"2018","journal-title":"Immunol Rev."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3389\/fimmu.2018.02162","article-title":"Rapamycin as an adjunctive therapy for NLRC4 associated macrophage activation syndrome","volume":"9","author":"Barsalou","year":"2018","journal-title":"Front Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/BOR.0000000000000093","article-title":"Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"26","author":"Weaver","year":"2014","journal-title":"Curr Opin Rheumatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00424-017-1945-7","article-title":"Physiological roles of macrophages","volume":"469","author":"Gordon","year":"2017","journal-title":"Pflugers Archiv Eur J Physiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1074-7613(00)80402-1","article-title":"MyD88: an adapter that recruits IRAK to the IL-1 receptor complex","volume":"7","author":"Wesche","year":"1997","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","article-title":"IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling","volume":"278","author":"Muzio","year":"1997","journal-title":"Science"},{"key":"B117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","article-title":"MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways","volume":"2","author":"Medzhitov","year":"1998","journal-title":"Mol Cell"},{"key":"B118","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1182\/blood-2011-01-329607","article-title":"Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice","volume":"117","author":"Krebs","year":"2011","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/art.33496","article-title":"Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome","volume":"64","author":"Strippoli","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J Pediatr."},{"key":"B122","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B123","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.4049\/jimmunol.164.6.3095","article-title":"CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity","volume":"164","author":"Hermans","year":"2000","journal-title":"J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1073\/pnas.0509054103","article-title":"Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo","volume":"103","author":"Yang","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","article-title":"Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8+ T cells and dendritic cells","volume":"121","author":"Terrell","year":"2013","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1182\/blood-2010-12-324533","article-title":"Perforin is a critical physiologic regulator of T-cell activation","volume":"118","author":"Lykens","year":"2011","journal-title":"Blood"},{"key":"B128","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12985-017-0908-0","article-title":"Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis","volume":"14","author":"Brisse","year":"2017","journal-title":"Virol J."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T21:02:24Z","timestamp":1573851744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":128,"alternative-id":["10.3389\/fimmu.2019.00119"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00119","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"article-number":"119"}}